Washington, DC - ConAgra Foods Packaged Foods, LLC, a Council Bluffs, Iowa establishment, is recalling approximately 84,340 pounds of two beef products due to misbranding and an undeclared allergen, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today. The products were inadvertently formulated with Worcestershire sauce and may contain fish (anchovies), a known allergen that is not declared on the product label. 

San Diego, California - A diabetes medication described in some studies as an effective treatment for nonalcoholic fatty liver disease (NAFLD) works no better than a placebo, report researchers at University of California San Diego School of Medicine, after conducting the first randomized, double-blind, controlled clinical trial of sitagliptin, an oral antihyperglycemic marketed by Merck & Co. under the name Januvia.

Los Angeles, California - Focusing on levels of anti-mullerian hormone, which is produced by cells in the ovarian follicles and is a marker of ovarian functioning, researchers analyzed data from 474 participants in the multi-ethnic, multi-site Study of Women’s Health Across the Nation. The women were between 42 and 52 years old, were pre- or early perimenopausal, had an intact uterus with one or two ovaries, and were not taking supplemental sex hormones.

Cambridge, Massachusetts - Many diseases, such as cancer, diabetes, and schizophrenia, tend to be passed down through families. After researchers sequenced the human genome about 15 years ago, they had high hopes that this trove of information would reveal the genes that underlie these strongly heritable diseases.

Los Angeles, California - Inner peace and a flexible body may not be the most valuable benefits that yoga and meditation have to offer, suggests new research by a UCLA-led team of neuroscientists.

Atlanta, Georgia - A new report assesses how the nation fared against the ambitious challenge goal set by the American Cancer Society to reduce the cancer death rates by 50% over 25 years ending in 2015.  The report finds areas where progress was substantial, and others where it was not. The report, appearing in the American Cancer Society journal, CA: A Cancer Journal for Clinicians, says the best improvements were seen in cancers for which prevention, early detection, and treatment tools are available, including cancers of the lung, colon, breast, and prostate.